Fulvestrant

• Description:

  Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  606.77

• Molecular Formula:

  C32H47F5O3S

• Notes:

  Research use only, not for human use.

• Receptor:

  ER

• CAS Number:

  129453-61-8